By Stephen Simpson, CFA : Investors can be a fickle bunch. While they will happily reward strong growth stories with eye-popping valuation multiples, they can be demanding when it comes to the timing of that growth and the marketing/investment spending that the company has to do to generate it. ...
Trinity Biotech plc ( TRIB ) Q4 2013 Earnings Conference Call March 04, 2014 11:00 AM ET Executives Joe Diaz – Managing Partner-Lytham Partners LLC Kevin Tansley – Chief
150; pg 20]; global energy producer Hess [ HES ; pg 22]; medical testing equipment/instrument maker Trinity Biotech [ TRIB ; for diabetes at $25,000/device, Lyme disease, autoimmune disorders, herpes, syphilis, strep pneumonia, cardiac evaluation
spinoff from Kraft ( KFT ) whose new ticker will be KRFT ; pg 16); diabetes and other testing equipment maker Trinity Biotech ( TRIB ; pg 19); Steelcase ( SCS ; pg 20; see link below). SCS story http://online.barrons.com/article/SB50001424053111904414004578016383267957450